Panel: Targeted Radiotherapy and the Impact on IO
PharmaTalkRadio11 Jan 2023

Panel: Targeted Radiotherapy and the Impact on IO

What is the impact of targeted radiotherapy on the immune system?What are the implications for combination IO?Current approaches and future direction Moderated by: Michael Groaning, PhD, Global Medical Affairs Lead, Genitourinary, Amgen Panelists: Charles Glaus, PhD, Sr Director, Radiomics & Radiology Biomarkers, Bayer US-PharmaceuticalsJeff Legos, PhD, MBA, EVP, Global Head of Oncology & Hematology Development , NovartisMatthew Silva, PhD, CEO , InvicroOhad Ilovich, PhD, Senior Director, Translational Sciences, Curie Therapeutics Learn more about the IO360° Summit at www.io360summit.com

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(461)

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
rss-ufobortom-rimligt-tvivel
svd-nyhetsartiklar
rss-vetenskapsradion
det-morka-psyket
rss-spraket
paranormalt-med-caroline-giertz
sexet
halsorevolutionen
rss-vetenskapsradion-2
rss-odla
rss-broccolipodden-en-podcast-som-inte-handlar-om-broccoli
medicinvetarna
dumforklarat
rss-ronden
rss-italiensk-dagbok
vetenskapsradion